Course Of Allergic Diseases Research Articles

Prevalence and Regional Factors in the Development and Course of Allergic Diseases in Children in Southern Kyrgyzstan

Background: The prevalence of allergic diseases in children worldwide has increased rapidly over the past 30 years. This study aimed to identify regional factors influencing the development and course of allergic diseases for further prevention, control, and reduction of the risk and frequency of complications. Methods: To investigate the issue, 104 studies by different authors and countries, as well as topics related to allergy in children, air pollution, and regional factors of detection and prevalence of this disease in Kyrgyzstan, were selected. Of these, 52 studies were noted and analysed, which met the selection criteria and were of direct importance in this topic. Results: This study of allergic diseases in children found that more than 35% of children worldwide suffer from allergic diseases. Of these, allergic rhinitis occurs in 12% of children, atopic dermatitis is less common, but its incidence is 10-20%, and bronchial asthma, according to statistics, covers more than 14% of children. Conclusion: The results of the study helped to investigate the prevalence of allergic diseases relative to the region of residence, the impact of environmental pollution, geographical significance, and the effect of smoking on the development of allergies in children.

Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults

Allergen-specific immunotherapy is a method of treatment and prevention of respiratory allergic diseases. Carrying it out changes and improves the course of allergic diseases. One of the promising and new approaches is the combination of allergen-specific immunotherapy with one of the biological drugs, omalizumab. Currently, few such studies have been carried out in the world. 14 works were selected from international databases (eLibrary.ru, PubMed, Embase, Cochrane, Web of Science). Their results were analyzed and summarized. The characteristics of these studies and their design are given. The results of the safety and effectiveness of the combined use of allergen-specific treatment and anti-IgE therapy are described. It was shown that in most cases (13 out of 14), omalizumab therapy precedes allergen-specific immunotherapy. However, the duration of combination treatment, drug regimens, and patient monitoring vary significantly. All studies have established a variety of positive effects of the combined use of omalizumab and allergen-specific immunotherapy (improvement of the course of diseases, increased possibility of treatment with allergens, good tolerability of drugs, etc.). These studies are very promising. Their continuation is required. It is necessary to clarify the most rational schemes for the combined use of anti-IgE and allergen-specific immunotherapy.

The role of selenium in the functioning of immune system components and the incidence of allergies: a content analysis of recent literature

Selenium is an essential trace element. Adequate intake of selenium is necessary for optimal functioning of cellular and humoral processes in the body. Lack of selenium in the diet can lead to aggravation of infectious and allergic diseases and also increase the risk of tumor formation. This review article provides data on the metabolic pathways of selenium and its role in the immune system, as well as the occurrence of allergies and antitumor and antioxidant protection. In detail, the role of selenium is discussed in relation to the implementation of body antiviral defenses. Under conditions of selenium deficiency, numerous viral infections are linked to an unfavorable prognosis, and this article specifically considers the problem of myocarditis occurring during viral infections, summarizing data on the pathogenesis of the condition and possible connections with selenium deficiency. The results of content analysis demonstrate that selenium, participating in the synthesis of selenium-containing enzymes and selenoproteins, ensures the functioning and activity of innate and acquired immunity, antitumour and antioxidant defence, which indirectly affects the course of allergic diseases. Selenium deficiency increases the incidence of allergies, tumours and infections, especially viral infections. In case of viral infections, not only the course of immune reactions depends on sufficient amount of selenium in the organism, but also the possibility of increasing the virulence of the pathogen in case of selenium deficiency. In the case of a severe course of the disease, the main symptoms of infection may be joined by other, more serious manifestations, such as myocarditis. The antioxidant, immunostimulant and antiviral properties of selenium ensure its modifying role in the development of diseases and the percentage of fatalities. Rational consumption of selenium may be of great importance in the prevention, course and determination of outcomes of many diseases, including allergopathology.

Cow's Milk Allergy May Induce Lipid Metabolism Disorder in BALB/c Mice via Exosomes.

Allergic diseases and lipid-metabolism-disorder-derived diseases are both significant public health issues. Recent studies have shown that exosomes are associated with the course of allergic diseases and are involved in lipid metabolism. In this study, exosomes derived from cow's milk allergic (CMA) mice medially loaded lesser proteins favoring cholesterol metabolism. The levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) in the serum were increased in the CMA mice, and hepatic lipid deposition was observed in the liver, but these phenomena were improved by inhibiting the exosome release. Specifically, the higher expression of the sterol regulatory element binding factor 2 (SREBP2) protein and HMGCR gene in the liver of CMA mice indicated an increase in cholesterol synthesis. NPC1L1 was also highly expressed in the small intestine of CMA mice, and fecal TC level was decreased, suggesting that the reabsorption of cholesterol was elevated. The biosynthesis of cholesterol, the reverse cholesterol transport (RCT) process, and the synthesis of bile acid in the liver were improved by inhibiting exosome release, as well as the reabsorption of cholesterol in the small intestine. This study has for the first time demonstrated the lipid metabolism disorder caused by CMA, especially the important role of exosomes in food allergies and lipid metabolism.

Vitamin D and allergic diseases.

In recent years, the relationship between vitamin D and allergic diseases has received widespread attention. As a fat-soluble vitamin, vitamin D plays a crucial role in regulating the immune system and may influence the onset and progression of diseases such as atopic dermatitis, allergic rhinitis, and asthma. To understand the underlying mechanisms, we have summarized the current research on the association between vitamin D and allergic diseases. We also discuss the impact of vitamin D on the immune system and its role in the course of allergic diseases, particularly focusing on how vitamin D supplementation affects the treatment outcomes of these conditions. We aim to provide a theoretical basis and practical guidance for optimizing the management and treatment of allergic diseases by modulating vitamin D levels.

Allergen Immunotherapy for a Year Can Effectively Reduce the Risk of Postoperative Recurrence of Adenoid Hypertrophy in Children with Concurrent Allergic Rhinitis (IMPROVEII).

Adenoid hypertrophy (AH) and allergic rhinitis (AR) are common pediatric diseases, seriously affecting the quality of life and growth of children. The recurrence rate of AH is higher for patients with than for those without concurrent AR. Allergen specific immunotherapy (AIT) is the only effective therapy for modifying the course of allergic diseases. This study sought to investigate the efficacy of AIT in preventing AH recurrence in patients with AR who underwent adenoidectomy. This study included 134 children aged 5-12 years with concurrent AH and AR. They were separated into the subcutaneous immunotherapy (SCIT) group treated with a double-mite allergen preparation or the non-AIT group treated symptomatically with only medications. The adenoid/nasopharyngeal ratio at one year after adenoidectomy was used to assess AH recurrence. The Obstructive Sleep Apnoea Questionnaire (OSA-18), Paediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ), and Visual Analogue Scale (VAS) were used to assess the severity of the sleep disorders and AR. This study included 62 and 72 children with concurrent AH and AR in the SCIT and non-AIT groups, respectively. The rate of recurrence in the SCIT group was significantly lower than that in the non-AIT group (4.84% vs.16.67%; P=0.030). The OSA-18, PRQLQ, and VAS scores were significantly lower for the SCIT than (P<0.001) for the non-AIT group after one year of treatment. The findings suggest that AIT should be considered the preferred therapy for reducing postoperative recurrence of AH in children with concurrent AR following adenoidectomy, but further research is needed to confirm these findings in a larger population.

Dermatophagoides pteronyssinus proteins and their role in the diagnostics and management of house dust mite allergy: exploring allergenic components.

Component-resolved diagnostics enables the detection of allergen-specific immunoglobulins E (asIgE) to house dust mite (HDM) proteins, which may help clinicians to face the difficulties in diagnostics of HDM allergy. Currently, almost 40 proteins of Dermatophagoides species, that are able to bind asIgE, have been identified, and this number will certainly increase. The association between sensitisation to particular molecules and allergy symptoms is extensively studied. This investigation enables us to identify HDM molecules that promote respiratory, skin, or food allergies, and it could help us predict the possible course of allergic diseases. The individual repertoire of asIgE improves our understanding of immunological response, which underlies allergy symptoms, and helps to form individual therapeutic regimens. This review provides clinicians with information on Dermatophagoides pteronyssinus proteins available in commercial arrays, and their role in the diagnostics and management of HDM allergy.

The role of Helicobacter pylori infection in the development and course of allergic diseases in children with gastroesophageal reflux disease

Objective — to improve the prevention and treatment of esophageal lesions in children based on the study of Helicobacter pylori infection in pediatric patients with allergic diseases.&#x0D; Materials and methods. Examination involved 256 children aged 6 to 18 years, from them 118 children without allergic pathology were included in the control group. The diagnosis was verified according to the unified clinical protocols of primary and secondary medical care. H. pylori was determined with biopsy urease test or histologically. Video esophagogastroduodenoscopy with endoscopic determination of pH was used to assess the condition of mucosa of the upper gastrointestinal parts. The results were processed using the methods of non‑parametric statistics.&#x0D; Results. Helicobacter pylori infection occurred more often in children with atopic dermatitis (32%), less often and equally often (24%) at bronchial asthma and allergic rhinitis and in 16% of patients with a combination of allergic diseases. Only 2 (1.4%) patients had H. pylori‑associated chronic urticaria, which was related to the specificity of the hospital department. Helicobacter infection was observed more often in patients with allergic rhinitis and atopic dermatitis without atopic changes. When comparing the Helicobacter association in children with allergic diseases depending on age, a significant difference was established in the group of children aged 6—12 years with allergic rhinitis and mainly with atopy. Endoscopic changes in the esophageal mucosa and esophageal motility disorders in association with Helicobacter pylori more often diagnosed in patients with atopic dermatitis (10.3%), less often and equally often in patients with bronchial asthma and allergic rhinitis (7.7%), the lowest frequency of Helicobacter pylori infection was found in patients with combined allergic pathology (5.1%) and no association in patients with urticaria. Endoscopic signs of esophageal inflammation were more often detected in patients with atopic dermatitis who had Helicobacter pylori infection and esophageal motility disorders. Most often, inflammatory changes in esophageal mucosa were found in patients with allergies developed in the presence of motor disorders, the risk of their development increased in case of Helicobacter infection. It has not been proven that the presence of atopy affected the development of inflammation in the esophagus.&#x0D; Conclusions. Among allergic diseases, Helicobacter pylori infection was more often revealed in patients with atopic dermatitis (32%), allergic rhinitis (24%) and bronchial asthma (24%) without statistical significance. A significant difference in H. pylori contamination depending on age was found only in patients with allergic rhinitis (H. pylori was determined more often in elementary school age), in the rest of the patients and in the control group, no significant differences were found. Endoscopic lesions of the esophagus were more often detected in atopic dermatitis, in particular esophagitis (in 17.9%), it was Helicobacter‑associated in 10.3% of cases and was combined with moderate motor disorders in 10.3% of observations. Allergic rhinitis (15.4%) was also associated with Helicobacter pylori infection (7.7%) and was accompanied by motility disorders in 15.4% of cases. Motor disorders, which were registered both in patients with allergic diseases and in patients without allergies, played an important role in the esophagus inflammation and formation of gastroesophageal reflux disease.&#x0D;

Tropomyosins of the helminthes: Sensitization and association with allergic diseases

The increase in the prevalence of allergic diseases has been a driver of the development of new technologies. Over the past two decades, significant progress in biochemistry and molecular allergology has contributed to the study of the structure of allergens and development of component-resolved diagnostics. Specifically, clinically significant families of allergens have been identified, including tropomyosin, which can cause various cross-IgE-mediated reactions. One of the risk factors for sensitization development is helminthiasis, which is common in different regions and population of endemic areas. The global prevalence of helminthiasis remains high. Approximately 1.5 billion people worldwide have chronic infections with at least one helminth.&#x0D; This review aimed to analyze current studies determining the relationship between helminth infections and the development of sensitization to helminth tropomyosin and clinical course of allergic diseases.&#x0D; The analysis of scientific publications described the relationship between helminth tropomyosin and the development of allergic diseases and sensitization in patients with parasitic infection. The PubMed database was used for the review. The review included original articles published between January 1, 2000, and December 31, 2021.

Efficacy and Safety of Oral Probiotics in Children with Allergic Rhinitis: A Review

The prevalence of allergic rhinitis is rising, and it is impacting children’s growth and quality of life. To uncover unconventional treatment modalities, research was carried out to clarify the significance of novel components in the pathophysiology of allergic rhinitis. One of these elements was gut microbiota, which plays a crucial role in the development and evolution of allergic disorders. Specifically, dysbiosis, defined as impaired microbiota composition, characterizes allergic disorders. In light of this concept, probiotics (beneficial bacteria) may restore gut dysbiosis, rebalance the immune response, and indirectly influence the clinical course of allergic diseases. In this article, we discussed the role of the gut–lung axis in children and reported on new findings. We also reviewed the most relevant studies about probiotics in patients with allergic rhinitis.

Acute urticaria in children: course of the disease, features of skin microbiom

Quantitative and qualitative changes in the microbiome of the skin affect the emergence and course of allergic diseases, in particular, of acute urticaria. Aims: to investigate the taxonomic composition of the skin microbiota in children with acute urticaria and to study its effect on the course of the disease. In total, 75 children with diagnosed acute urticaria at the age of 7-14 years were examined. The average age of children was 10.83±0.95, of which 44 were boys (58.7%), and 31 were girls (41.3%). The control group consisted of 30 virtually healthy children of the appropriate age, of whom 16 were boys (53.3%), and 13 were girls (46.7%). Regardless of the severity of the disease, the examined children suffering from acute urticaria had sensitization in history with a significant prevalence of food sensitization (p&lt;0.05). The occurrence of a severe episode of acute urticaria is associated with allergens of drug origin in 52.6% of cases and the action of unidentified triggers in 47.4% of cases. In children with acute urticaria, S. epidermidis, S. aureus, bacteria of the genus Peptococcus, and Peptostreptococcus dominated on a non-affected skin area, while for affected skin area, the Propionibacterium, S. aureus, S. epidermidis, bacteria of the genus Peptococcus, Propionibacterium, and Peptostreptococcus were denoted as dominating. High frequency of S. aureus detection on affected and non- affected skin areas in children with acute urticaria is a predictor of the disease's severity.

Investigations on incidence and relevant factors of allergies in 5725 urban pregnant women: a cohort study in China

BackgroundAllergic diseases are highly prevalent in the women of childbearing age. As we know, the immune system could change when pregnancy, which may affect the course of allergic diseases. Meanwhile, they also can affect the course and outcome of pregnancy. The data on incidence of allergies during pregnancy is lacking and conducting clinical trials in pregnant women was limited, therefore, we observed a prebirth cohort to supplement the relevant data and strengthen concerned research conductions.ObjectiveWe aim to obtain the incidence of allergies in urban pregnancy and explore the relevant factors of allergic diseases in urban pregnancy.MethodsWe design a multicenter and prospective cohort in 20 institutions above municipal level which were eligible according to the study design from 14 provinces covering all-side of China. This cohort was conducted from 13+6 weeks of gestation to 12 months postpartum and in our study, we chose the prenatal part to analyze. The outcome was developing allergies during pregnancy, which were diagnosed by clinicians according to the uniform criterion from National Health Commission. All the data was collected by electronic questionnaires through tablet computers.ResultsThe incidence of allergic diseases in urban pregnant women was 21.0% (95%CI 20.0% ~ 22.0%). From social demography data, the history of allergies of pregnant women and their parents had statistical significance(p < 0.01); For exposure to living or working environment, house decoration for less than half a year, exposure to plush toys, disinfectants, insecticides, antihistamines, glucocorticoids, antipyretic analgesics, tocolytic agent and probiotics had statistical significance (all p < 0.05); For psychological status, self-rated depression and anxiety had statistical significance (p = 0.026;p = 0.006).ConclusionThe incidence of allergic diseases in urban pregnant women was similar to the former study and kept a medium–high level. The history of allergies of pregnant women and their parents, house decoration time, exposure to plush toys, disinfectants, insecticides, antihistamines, glucocorticoids, antipyretic analgesics, tocolytic agents, probiotics, self-rated depression, and anxiety were relevant factors of allergic diseases during pregnancy.

Association between exposure to greenness and atopic march in children and adults-A systematic review and meta-analysis.

Allergic diseases are a global public health problem. Food allergy, atopic dermatitis (AD), allergic rhinoconjunctivitis, allergic rhinitis (AR) and asthma represent the natural course of allergic diseases, also known as the "atopic march". In recent years, a large number of studies have been published on the association between greenness exposure and allergic diseases. However, systematic reviews on the association between greenness exposure and multiple allergic diseases or atopic march are lacking. In this study, PubMed, EMBASE, ISI Web of Science, and Scopus were systematically searched. Meta-analyses were performed if at least three studies reported risk estimates for the same outcome and exposure measures. Of 2355 records, 48 studies were included for qualitative review. Five birth cohort studies, five cross-sectional studies, and one case-control study were included for asthma meta-analysis, respectively. Four birth cohort studies were included for AR meta-analysis. Our results support that exposure to a greener environment at birth reduces the risk of asthma and AR in childhood. In addition, higher greenness exposure was associated with decreased odds of current asthma in children. There was a large heterogeneity among the included studies and most of them did not specify the vegetation type and causative allergens. Therefore the study results need to be further validated. In addition, a small number of studies evaluated the association between greenness and food allergy, AD and allergic rhinoconjunctivitis. More research is needed to strengthen our understanding of the association between greenness and allergic diseases.

The results of the use of a combined probiotic (Lactobacillus rhamnosus GG and Bifidobacterium animalis spp. lactis ВB-12) in children with gastrointestinal and skin manifestations of food allergy

At present, there are sufficient data on the influence of the gut microbiome on the development of food allergy and its progression. Changes in gut microbiome composition could positive impact on the course of allergic diseases by means of regulating the ratio of pro- and anti-inflammatory cytokines, as well as immunoglobulin E level. The purpose of the research was to study the effectiveness of combined probiotic in treatment of food allergies in children. Material and methods. The prospective randomized controlled study included 92 children aged from 4 to 5 years with symptoms of food allergy, involving the skin and gastrointestinal tract. The main group (n=46) took two chewable tablet Bifiform Kids (Lactobacillus rhamnosus GG >1x109 CFU, Bifidobacterium animalis spp. lactis BB-12 >1x109 CFU, thiamine mononitrate 0.40 mg, pyridoxine hydrochloride 0.50 mg per tablet) 2 times per day during 21 days. The control group (n=46) did not take the complex. The dynamics of the severity of food allergy skin symptoms was assessed using the SCORAD index, of gastrointestinal manifestations - on a point scale after 21 days and after 4 and 6 months (visits 2, 3 and 4). The concentration of immunoglobulin E, interleukins IL-17 and IL-10 was determined by enzyme immunoassay in blood serum at the baseline, as well as after 21 days and after 6 months (visits 1, 2 and 4) after the study initiation. Results. The SCORAD index among children from the main group decreased from 12.4±2.3 до 7.6±1.8 (р=<0.05) while taking a combined probiotic. It was significantly lower (р=<0.05) compared to the control group (SCORAD index changed from 12.1±2.4 to 12.2±1.9). On the 21st day, a statistically significant decrease in level of pro-inflammatory IL-17 (by 27%) and a statistically significant increase in the concentration of anti-inflammatory IL-10 (by 38.9%) were recorded. In children from the main group, the severity of such gastrointestinal symptoms as pain, rumbling in the abdomen, belching with air, bloating, gas discharge, increased stool and its unformularity, decreased compare to the control group of patients (р=<0.05), in which the intensity of complaints related to gastrointestinal manifestations did not change. In the main group of patients, the most clinical efficacy was noted immediately after the end of the probiotic intake. In the following five months, the intensity of symptoms increased in individual subjects from the main group, but in general, the intensity of complaints remained significantly lower than before probiotic intake (р=<0.05). Children from the main group showed a significant decrease in IgE level from 184±121 kU/l by 43.5% at visit 2 and by 38.0% at visit 4 (p=<0.05), while in children from the control group its level didn't change, amounting to 176±141, 165±121 and 178±132 kU/l, respectively. Conclusion. The results of the study show the effectiveness of the use of a combined probiotic (Lactobacillus rhamnosus GG, Bifidobacterium animalis spp. lactis ВB-12) with vitamins B1 and B6 in children with mild forms of gastrointestinal and skin manifestations of food allergy, both in relation to the severity reduction of the clinical symptoms of the disease (skin manifestations, pain, rumbling in the abdomen, belching with air, bloating, gas discharge, increased stool and its unformularity), and in relation to the dynamics of biochemical parameters - a decrease in the level of IgE.

Update on allergenic immunotherapy for asthma and rhinoconjunctivitis

Allergenic immunotherapy consists of repeated administration of allergenic extracts to which an individual is allergic. It is currently the only treatment that modifies the course of allergic disease and induces short- as well as long-term remission of symptoms. Two formulations are currently available: subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT), with comparable efficacy. In specific situations, it can be used in combination with the new approved biologic therapies for asthma to improve tolerance of immunotherapy.

Забезпеченість вітаміном D та вплив його дефіциту на перебіг алергічних захворювань у дітей

The prevalence of allergic pathology is increasing significantly in both adults and children, and at the same time, the problem of vitamin D deficiency remains relevant. Recent studies have revealed a close connection between vitamin D deficiency and the development of allergic diseases in children. In addition to its role in bone and calcium metabolism, recent observations have shown its possible role as an immunomodulator in allergic diseases. This is due to the presence of vitamin D receptors in most cells of the human body. One of the most important functions of vitamin D is to modulate the response of the immune system, both innate and adaptive. Currently, there is no consensus on the possible mechanisms of vitamin D involvement in the pathogenesis of allergies. It is believed that the role of vitamin D in the pathogenesis of allergic diseases is due to its regulatory effect on the immune system, participation in antimicrobial protection and ensuring the barrier function of the skin and mucous membranes. In this regard, considerable attention is paid to the study of the role of vitamin D in the development and course of allergic diseases in children. Purpose - to summarize the literature data on the biological role of vitamin D and the impact of its deficiency on the course of allergic diseases in children. Results and conclusions. In most scientific studies, the adverse effect of vitamin D deficiency on the allergic process has been established - an insufficient level of 25(OH)D in blood serum was found in children with asthma, allergic rhinitis, atopic dermatitis and food allergies. Also, a number of authors found a connection between the status of vitamin D and the risk of development and exacerbation of an allergic disease or indicators of a severe course. Although other researchers deny such relationship. Despite the inconsistencies in the literature, it is possible to note the important role of vitamin D in the development and course of allergic diseases in children. No conflict of interests was declared by the authors.

Impact of coronavirus pandemic on safety and time of administration of subcutaneous immunotherapy among pediatric patients

Introduction: Allergen immunotherapy is the only targeted therapy that can modify the natural course of allergic diseases. In pediatric patients, SCIT with aeroallergens is an effective treatment and should be considered as a preventive strategy in the treatment of allergic diseases, even though one of the major concerns about it is its safety. The main purposes of this study were to assess the safety of SCIT ultra-rush schedules with polymerized extracts in a pediatric population and to determine the impact of the COVID-19 pandemic on the safety and time of administration of subcutaneous immunotherapy among pediatric patients. Methods: A retrospective medical records review of patients under 18 years of age undergoing SCIT was made and re-scheduling due to restrictions imposed by the COVID-19 pandemic was recorded. Results: A total of 192 pediatric patients were included. Fifty-nine (31%) had local reactions and systemic reactions were not reported. In March 2020, the first case of COVID-19 was diagnosed in Portugal and all non-urgent appointments and procedures were postponed. In our group of pediatric patients, 43 (22%) were referred to primary care, 38 (20%) stopped AIT definitively and 111 (58%) maintained administrations in the hospital. Only 2 (2%) of them had reactions upon reinitiation. Conclusion: In this study, the ultra-rush protocol using polymerized extracts was safe in pediatric patients. Although the effectiveness of AIT may be compromised due to prolonged suspension of the treatment, it is important to note that despite longer interruptions, administrations may continue without compromising safety, maintaining shorter visits and a lower number of injections.

Can we alter the course of allergic disease?

In the period between 1870 and 2020, several different allergic diseases have emerged (Fig 1). The role of pollen grains in hay fever was defined by Blackley in 1873; Prausnitz coined the term allergy in 1905; immunotherapy (IT) was introduced by Noon in 1911; asthma became a major disease of childhood between 1960 and 2000. Finally, multiple forms of food allergy erupted between 1980 and 2010.1 Given the multiple different syndromes of allergic disease, it is obvious that there cannot be a simple explanation for their appearance or increase in prevalence at such different times.

Atopic march in children with early-onset atopic dermatitis: A retrospective study

BackgroundAtopic march is a term that describes the progression of atopic disorders, from atopic dermatitis in young infants and toddlers to allergic rhinitis and asthma in later childhood. The aim of this study was to elucidate the course of allergic diseases between 3-7 years of age in patients with atopic dermatitis in the first 2 years of life. MethodsA total of 211 children have been analyzed in this retrospective study. The atopic dermatitis group consisted of 119 children diagnosed with atopic dermatitis between the ages of 0–2 in 2013 and the control group consisted of 92 children aged 0-3 months who had a hearing test for screening in the same year. The diagnoses of wheezing, atopic dermatitis, and allergic rhinitis in both groups below 2 years old and between 3-7 years old were examined from the hospital database and government e-health service. ResultsThe frequency of at least one wheezing attack (28.6% vs. 29.3%), at least three wheezing attacks (15.1% vs. 9.8%) and allergic rhinitis (22.7% vs. 22.8%) were not significantly different between atopic dermatitis and control groups in children between 3 and 7 years old. However, in the atopic dermatitis group, the frequency of at least one wheezing attack (42.6% vs. 19.4%, P=0.006), at least three wheezing attacks (25.6% vs. 8.3%, P=0.011), and allergic rhinitis (38.3% vs. 12.5%, P=0.001) were significantly higher in children with food sensitization than individuals without food sensitization. ConclusionThis study showed that the later allergic respiratory diseases in children with early-onset atopic dermatitis were associated with food sensitization regardless of early wheezing, and the persistence of atopic dermatitis was associated with multiple food sensitizations.

Diagnostics of allergic diseases in HIV-infected patients using actual computer technologies

Purpose. Development of complex diagnostic methods and assessment of the course of allergic diseases in immunocompromised individuals with HIV infection based on the use of actual computer technologies to improve the quality of diagnostics and treatment measures in these patients.Materials and methods. Methods for calculating the relative increase and average growth rate used to estimate the annual increase in the number of diagnosed cases of allergic diseases in the Novgorod region. During the studying of the comorbidity of HIV and allergy we used information about a burdened allergic history. Additional parameters of the analysis were data, obtained in clinical laboratory. For analysis of the data we used Student’s t test (t) and Pearson’s x². The study used the principle of a diagnostic matrix, which allows transferring medical experience to IT solutions, such as DSS and their variants.Results. In the Novgorod region there has been an increase in the number of diagnosed cases of individual allergic diseases. Over 1020 registered cases of HIV infection among residents of the Novgorod region considered to study the comorbidity of HIV infection and allergies. Information about aggravated allergic anamnesis is indicated in 12% cases. Statistically significant (p&lt;0.012) correlation between high viral load and the development of drug allergy in HIV-infected patients with identified allergic pathology were shown. The indicators of the immune status showing specific markers of allergy in patients with HIV were studied. We developed the clinical decision support system (CDDS), which used to organize medical knowledge and optimize the diagnostics.&gt;˂ 0.012) correlation between high viral load and the development of drug allergy in HIV-infected patients with identified allergic pathology were shown. The indicators of the immune status showing specific markers of allergy in patients with HIV were studied. We developed the clinical decision support system (CDDS), which used to organize medical knowledge and optimize the diagnostics.